Skip to content

Ropana Vascular

Forward-emitting lithotripsy catheter for blocked arteries

Raised to date

$100K

of $1M offered across 1 Form D filing

Still open
$900K
Investors
1
Last filed
May 20, 2026

About

Ropana Vascular develops endovascular devices for cardiovascular disease. Its FirstPass catheter is a forward-emitting intravascular lithotripsy device designed to fracture calcium in peripheral chronic total occlusions so a guidewire can cross. FirstPass is under development and not FDA cleared.

Delivers lithotripsy energy forward from the catheter tip, while current IVL platforms mainly emit radially and need a guidewire across the lesion first.

Funding

  • Security to be acquiredFiled May 20, 2026Form D
    $100K/ $1M

Product

FirstPass IVL Catheter

Medical device

A forward-emitting intravascular lithotripsy catheter for crossing the calcified proximal cap of peripheral chronic total occlusions, currently in development.

  • Energy delivered forward from the catheter tip
  • No guidewire needed to cross first
  • Low-profile design with sizes planned for above and below the knee

Built for

Interventional cardiologists, vascular specialists and endovascular surgeons treating peripheral artery disease

People on file